LABORATORIOS FARMACEUTICOS ROVI - stock earnings

ROVI.MC Quarterly earnings

DateEarningsRevenue
2023Q3 52.2 million EUR 214.0 million EUR
2023Q2 19.2 million EUR 179.2 million EUR
2023Q1 47.5 million EUR 201.6 million EUR
2022Q4 78.2 million EUR 242.2 million EUR
2022Q3 40.9 million EUR 195.1 million EUR
2022Q2 27.6 million EUR 174.8 million EUR
2022Q1 53.0 million EUR 205.6 million EUR
2021Q4 54.1 million EUR 185.2 million EUR
2021Q3 47.9 million EUR 173.5 million EUR
2021Q2 27.2 million EUR 159.5 million EUR
2021Q1 23.8 million EUR 130.5 million EUR
2020Q4 14.2 million EUR 117.8 million EUR
2020Q3 17.2 million EUR 111.0 million EUR
2020Q2 15.7 million EUR 90.2 million EUR
2020Q1 13.9 million EUR 101.0 million EUR
2019Q4 8.6 million EUR 110.5 million EUR
2019Q3 14.5 million EUR 93.2 million EUR
2019Q2 9.3 million EUR 95.4 million EUR
2019Q1 6.9 million EUR 82.2 million EUR
2018Q4 2.2 million EUR 84.3 million EUR
2018Q3 8.1 million EUR 72.6 million EUR
2018Q2 712000 EUR 70.5 million EUR
2018Q1 6.8 million EUR 75.8 million EUR
2017Q4 221000 EUR 72.2 million EUR
2017Q3 1.3 million EUR 64.7 million EUR
2017Q2 9.4 million EUR 71.3 million EUR
2017Q1 6.4 million EUR 67.5 million EUR
2016Q4 4.6 million EUR 73.7 million EUR
2016Q3 3.5 million EUR 62.6 million EUR
2016Q2 8.6 million EUR 68.2 million EUR
2016Q1 9.4 million EUR 60.7 million EUR
2015Q4 3.3 million EUR 68.4 million EUR
2015Q3 2.9 million EUR 56.4 million EUR
2015Q2 7.1 million EUR 60.5 million EUR
2015Q1 6.5 million EUR 60.8 million EUR
2014Q4 4.3 million EUR 64.8 million EUR
2014Q3 4.9 million EUR 57.0 million EUR
2014Q2 9.0 million EUR 58.7 million EUR
2014Q1 5.9 million EUR 57.6 million EUR
2013Q4 4.3 million EUR 56.7 million EUR
2013Q3 4.8 million EUR 51.3 million EUR
2013Q2 8.5 million EUR 55.8 million EUR
2013Q1 5.3 million EUR 53.8 million EUR
2012Q4 6.6 million EUR 97.0 million EUR
2012Q3 3.7 million EUR 48.7 million EUR
2012Q2 7.7 million EUR 53.9 million EUR
2012Q1 5.3 million EUR 50.9 million EUR
2011Q4 5.3 million EUR 88.8 million EUR
2011Q3 2.9 million EUR 44.3 million EUR
2011Q2 8.0 million EUR 49.1 million EUR
2011Q1 4.9 million EUR 46.8 million EUR
2010Q4 -67000 EUR 44.2 million EUR
2010Q3 5.7 million EUR 41.7 million EUR
2010Q2 13.9 million EUR 39.4 million EUR
2010Q1 5.0 million EUR 33.3 million EUR
2009Q4 ? EUR 40.7 million EUR
2009Q3 ? EUR 40.7 million EUR
2009Q2 ? EUR 30.2 million EUR
2009Q1 ? EUR 30.2 million EUR
2008Q4 ? EUR 34.3 million EUR
2008Q3 ? EUR 34.3 million EUR
2008Q2 ? EUR 29.5 million EUR
2008Q1 ? EUR 29.5 million EUR
2007Q4 ? EUR 16.3 million EUR
2007Q2 ? EUR 20.1 million EUR
2007Q1 ? EUR 20.1 million EUR

ROVI.MC Yearly earnings

DateEarningsRevenue
2023 197.0 million EUR 837.1 million EUR
2022 199.7 million EUR 817.7 million EUR
2021 153.1 million EUR 648.7 million EUR
2020 61.1 million EUR 420.0 million EUR
2019 39.3 million EUR 381.3 million EUR
2018 17.9 million EUR 303.2 million EUR
2017 17.2 million EUR 275.6 million EUR
2016 26.1 million EUR 265.2 million EUR
2015 19.8 million EUR 246.0 million EUR
2014 24.1 million EUR 238.0 million EUR
2013 23.0 million EUR 217.6 million EUR
2012 19.5 million EUR 201.9 million EUR
2011 18.1 million EUR 184.7 million EUR
2010 24.6 million EUR 158.6 million EUR
2009 23.1 million EUR 115.2 million EUR
2008 23.5 million EUR 127.5 million EUR
2007 15.0 million EUR 100.7 million EUR
2006 5.1 million EUR 78.6 million EUR
2005 912.1 billion EUR 7.8 trillion EUR
2004 1.6 billion EUR 7.1 billion EUR
2003 ? EUR 48.1 million EUR

ROVI.MC

Price: €79.60

52 week price:
37.96
83.30

Dividend Yield: 0.01%

5-year range yield:
0.01%
2.49%

Forward Dividend Yield: 1.32%

Payout Ratio: 29.03%

Payout Ratio Range:
29.03%
95.48%

Dividend Per Share: 1.05 EUR

Earnings Per Share: 3.20 EUR

P/E Ratio: 17.96

Exchange: MCE

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 4.2 billion

Average Dividend Frequency: 1

Years Paying Dividends: 16

DGR3: 24.13%

Links: